26 related articles for article (PubMed ID: 31430699)
1. Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from
Tran HT; Solnier J; Pferschy-Wenzig EM; Kunert O; Martin L; Bhakta S; Huynh L; Le TM; Bauer R; Bucar F
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32650510
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Phage-Host Interaction Mechanism toward Improving the Efficacy of Current Antibiotics in
Gorzynski M; De Ville K; Week T; Jaramillo T; Danelishvili L
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239050
[TBL] [Abstract][Full Text] [Related]
3. Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against
Chen S; Teng T; Zhang Z; Shang Y; Xiao H; Jiang G; Wang F; Jia J; Dong L; Zhao L; Chu N; Huang H
Infect Drug Resist; 2021; 14():1199-1208. PubMed ID: 33790590
[TBL] [Abstract][Full Text] [Related]
4. Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.
Egorova A; Jackson M; Gavrilyuk V; Makarov V
Med Res Rev; 2021 Jul; 41(4):2350-2387. PubMed ID: 33645845
[TBL] [Abstract][Full Text] [Related]
5. Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models.
Saxena S; Spaink HP; Forn-Cuní G
Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33573039
[TBL] [Abstract][Full Text] [Related]
6. Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.
Rindi L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545436
[TBL] [Abstract][Full Text] [Related]
7. Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical,
Guo Q; Chen J; Zhang S; Zou Y; Zhang Y; Huang D; Zhang Z; Li B; Chu H
Infect Drug Resist; 2020; 13():447-454. PubMed ID: 32104016
[TBL] [Abstract][Full Text] [Related]
8. The Contribution of Efflux Pumps in
Vianna JS; Machado D; Ramis IB; Silva FP; Bierhals DV; Abril MA; von Groll A; Ramos DF; Lourenço MCS; Viveiros M; da Silva PEA
Antibiotics (Basel); 2019 Sep; 8(3):. PubMed ID: 31540480
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydropyridine derivative as efflux inhibitor in Mycobacterium abscessus.
Vianna JS; Ramis IB; Bierhals D; von Groll A; Ramos DF; Zanatta N; Lourenço MC; Viveiros M; Almeida da Silva PE
J Glob Antimicrob Resist; 2019 Jun; 17():296-299. PubMed ID: 30630106
[TBL] [Abstract][Full Text] [Related]
10. [Effects of four efflux pump inhibitors on the activities of clarithromycin against
Teng TL; Shang YY; Huang HR; Chu NH; Chen ST
Zhonghua Jie He He Hu Xi Za Zhi; 2022 May; 45(5):468-474. PubMed ID: 35527462
[No Abstract] [Full Text] [Related]
11. Efflux pump effects on levofloxacin resistance in
Teng T; Chen S; Huo F; Jia J; Zhao L; Jiang G; Wang F; Chu N; Huang H
Antimicrob Agents Chemother; 2024 May; 68(5):e0134823. PubMed ID: 38572960
[No Abstract] [Full Text] [Related]
12. Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus.
Ramis IB; Vianna JS; Reis AJ; von Groll A; Ramos DF; Viveiros M; da Silva PEA
Planta Med; 2018 Nov; 84(17):1265-1270. PubMed ID: 29913527
[TBL] [Abstract][Full Text] [Related]
13. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
[TBL] [Abstract][Full Text] [Related]
14. In silico and in vitro evaluation of tetrahydropyridine compounds as efflux inhibitors in Mycobacterium abscessus.
Ramis IB; Vianna JS; Silva Junior L; von Groll A; Ramos DF; Lobo MM; Zanatta N; Viveiros M; Silva PEAD
Tuberculosis (Edinb); 2019 Sep; 118():101853. PubMed ID: 31430699
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
